EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression

Yutaka Kato, Takahiro Fukazawa, Keiji Tanimoto, Masami Kanawa, Masato Kojima iD, Isamu Saeki, Sho Kurihara, Ryo Touge, Nobuyuki Hirohashi, Satoshi Okada, Eiso Hiyama iD

Cancer Science · 2024-03 · 115 (3) · 847-858

DOI: 10.1111/cas.16051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 05.01.2024. Verfasst von Yutaka Kato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achaete‐scute family bHLH transcription factor 2 (ASCL2) is highly expressed in hepatoblastoma (HB) tissues, but its role remains unclear. Thus, biological changes in the HB cell line HepG2 in response to induced ASCL2 expression were assessed. ASCL2 expression was induced in HepG2 cells using the Tet‐On 3G system, which includes doxycycline. Cell viability, proliferation activity, mobility, and stemness were evaluated using 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide, colony‐formation, migration, invasion, and sphere‐formation assays. Quantitative reverse‐transcription polymerase chain reaction was used to assess the expression of markers for proliferation ( CCND1 and MYC ), epithelial‐mesenchymal transition (EMT; SNAI1 , TWIST1 , and ZEB1 ), mesenchymal‐epithelial transition ( CDH1 ), and stemness ( KLF4 , POU5F1 , and SOX9 ). Compared with the non‐induced HepG2 cells, cells with induced ASCL2 expression showed significant increases in viability, colony number, migration area (%), and sphere number on days 7, 14, 8, and 7, respectively, and invasion area (%) after 90 h. Furthermore, induction of ASCL2 expression significantly upregulated CCND1 , MYC , POU5F1 , SOX9 , and KLF4 expression on days 2, 2, 3, 3, and 5, respectively, and increased the ratios of SNAI1 , TWIST1 , and ZEB1 to CDH1 on day 5. ASCL2 promoted the formation of malignant phenotypes in HepG2 cells, which may be correlated with the upregulation of the Wnt signaling pathway‐, EMT‐, and stemness‐related genes. ASCL2 activation may therefore be involved in the progression of HB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaLiver NeoplasmsHumansBasic Helix-Loop-Helix ProteinsCell Line, TumorGene Expression Regulation, NeoplasticEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Wnt signaling pathwaybasic helix-loop-helix transcription factorgrowthhepatoblastomaphenotype

Substanzen

Basic Helix-Loop-Helix ProteinsASCL2 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.
  • Division of Medical Research Support, Advanced Research Support Center, Ehime University, Toon, Japan.
  • Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Pediatric Surgery, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Masato Kojima, Eiso Hiyama

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Kato, Y., Fukazawa, T., Tanimoto, K., Kanawa, M., Kojima, M., Saeki, I., Kurihara, S., Touge, R., Hirohashi, N., Okada, S., & Hiyama, E. (2024). Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression. Cancer Science, 115(3), 847-858. https://doi.org/10.1111/cas.16051

Vancouver

Kato Y, Fukazawa T, Tanimoto K, Kanawa M, Kojima M, Saeki I, et al. Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression. Cancer Science. 2024;115(3):847-858. doi:10.1111/cas.16051

BibTeX
@article{Kato2024,
  author = {Kato, Yutaka and Fukazawa, Takahiro and Tanimoto, Keiji and Kanawa, Masami and Kojima, Masato and Saeki, Isamu and Kurihara, Sho and Touge, Ryo and Hirohashi, Nobuyuki and Okada, Satoshi and Hiyama, Eiso},
  title = {Achaete‐scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression},
  journal = {Cancer Science},
  year = {2024},
  volume = {115},
  number = {3},
  pages = {847--858},
  doi = {10.1111/cas.16051}
}
Kostenlos starten →